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permissive syncytia were formed with all seven HIV-1 isolates
that we tested, including those that were classified as nonsyncytium inducing in standard test cell lines. We show herein that
the formation of these DC-T-cell syncytia brings together
NF-KB or Rel proteins via the DC with Spl via the nonactivated T cell. The capacity of HIV-1 to induce heterologous
syncytia may lead to chronic unremitting virus replication in
the absence of standard stimuli.
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Productive infection of T cells with human
ABSTRACT
immunodeficiency virus 1 (HIV-1) typically requires that the
T cells be stimulated with antigens or mitogens. This requirement has been attributed to the activation of the transcription
factor NF-cB, which synergizes with the constitutive transcription factor Spl to drive the HIV-1 promoter. Recently, we
have found that vigorous replication of HIV-1 takes place in
nonactivated memory T cells after syncytium formation with
dendritic cells (DCs). These syncytia lack activated cells as
determined by an absence of staining for Ki-67 cell cycle
antigen. The expression and activity of NF-KcB and Spl were,
therefore, analyzed in isolated T cells and DCs from humans
and mice. We have used immunolabeling, Western blot analysis, and electrophoretic mobility shift and supershift assays.
T cells lack active NF-KB but express Spl as expected. DCs
express high levels of all known NF-KcB and Rel proteins, with
activity residing primarily within RelB, p50, and p65. However, DCs lack Spl, which may explain the failure of HIV-1 to
replicate in purified DCs. Coexpression of NF-KB and Spl
occurs in the heterologous DC-T-cell syncytia that are induced by HIV-1. Therefore, HIV-1-induced cell fusion brings
together factors that upregulate virus transcription. Since
DCs and memory T cells frequently traffic together in situ,
these unusual heterologous syncytia could develop in infected
individuals and lead to chronic HIV-1 replication without
ostensible immune stimulation.

MATERIALS AND METHODS
Antibodies. Antibodies to the NF-KB/Rel family and to Spl
were purchased from Santa Cruz Biotechnology; anti-Ki-67
(MIB-1) was from AMAC (Westbrook, ME); anti-HIV-1 p24
(15) was provided by The AIDS Research and Reagent
Program.
Cell Preparations. Mononuclear cells were isolated by flotation on Ficoll/Hypaque and separated into cell subsets as
described (16). Mixed leukocyte reactions were carried out
with 1 x 105 responding T cells and 3 X 103 allogeneic DCs.
Skin cell emigrants were prepared as described (14). Mouse
cells (DCs, T cells, B cells, and thioglycollate-elicited macrophages) were prepared by standard methods. Bone marrow
DCs were grown with granulocyte-macrophage colonystimulating factor from progenitors as described (17).
Infection of Cell Suspensions. Mixtures of allogeneic blood
DCs and T cells (mixed leukocyte reaction) or 1 x 105 viable
skin cell emigrants were added to wells of a 96-well roundbottom well plate. Live HIV-1IIIB was added for 1.5 h at 37°C
at a multiplicity of infection of 0.05-0.1 (13). The cells were
then washed and cultured for 5-6 days.
Immunolabeling of Cells. For immunocytochemistry, the
slides were incubated for 1 h with the primary antibody (0.3
,ug/ml), and bound antibody was detected by horseradish
peroxidase-conjugated secondary antibody and diaminobenzidine. For immunofluorescence, cells were incubated with the
primary antibody (0.3 ,g/ml) followed by fluorescein isothiocyanate-coupled anti-mouse or Texas red-coupled anti-rabbit
immunoglobulin.
Western Blot Analysis. Western blot analysis was carried out
by using 10 ,ug of cell lysates. Primary antibody (0.1 ,ug/ml) was
added in 5% (vol/vol) milk. Proteins were visualized with
ECL.
DNA-Protein Binding [Electrophoretic Mobility Shift Assay (EMSA)J Assay. The EMSA was performed as described
(18). The sequences of the oligonucleotides were as follows:
SPi, 5'-ATTCGATCGGGGCGGGGCGAGC-3'; SP1 mutant, 5'-ATTCGATCGGIICGGGGCGAGC-3'; NF-KB, 5'AGTTGAGGGGACTTTCCCAGGC-3'; NF-KB mutant, 5'AGTTGAGGCGACTTTCCCAGG-3' (mutations are underlined). Nuclear and cytosolic fractions were prepared by a

Human immunodeficiency virus 1 (HIV-1) replicates in cultured T cells that have been stimulated by antigens or mitogens
(1-4). Stimulation activates NF-KB or Rel transcription factors
(5), which can then drive corresponding NF-KB sites in the
HIV-1 promoter (6). The HIV-1 promoter also contains
essential Spl sites (6, 7), but Spl factors are expressed
constitutively in the nuclei of most cells (8). However, antigenic activation of T cells may not be essential for HIV-1
replication in infected individuals. For example, these individuals lose T-cell memory for antigens to which they are no
longer being exposed (9, 10). Recent data on the substantial
rate of HIV-1 replication in vivo also suggests some stable
chronic stimulus for virus replication (11, 12). The need for
T-cell activation for HIV-1 replication became of interest to us
when we identified a system in which mixtures of dendritic cells
(DCs) and small-sized T cells, carrying a memory phenotype,
supported vigorous infections with HIV-1 (13). The T lymphocytes did not show critical features of cell activation since
there was an absence of the Ki-67 cell cycle antigen, surface
interleukin 2 receptors, and HLA-DR antigens (13, 14). When
these mixtures of DCs and T cells were exposed to several
different isolates of HIV-1, the newly synthesized HIV-1 gag
proteins and virions were confined to heterologous syncytia
(DCs + T cells) that were induced by the virus (13). These
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Abbreviations: HIV, human immunodeficiency virus; EMSA, electrophoretic mobility shift assay; DC, dendritic cell.
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standard protocol (18, 19). From 3 to 10 ,ug of proteins was
used for each reaction.
In Vitro Transcription. The template and the conditions of
the assay were as described (20). The template carries the
HIV-1 promoter sequences from positions -109 to -8 followed by the adenoviruses major late initiator element from
positions -7 to +9 and a 379-bp G-free cassette. Nuclear
extracts (25-75 ,ug) were used in these reactions. Recombinant
Spl was from Promega.

RESULTS
HIV-1 Replicates in Mixtures of DCs and T Cells in the
Absence of Cell Proliferation. It was first essential to extend
the evidence that T-cell proliferation is not required for HIV-1
replication in mixtures of DCs and ostensible nonactivated T
cells from skin. Skin was chosen since in many respects it
resembles the lining of the organs involved in sexual transmission of HIV-1, and both DCs and T cells chronically traffic in
cutaneous afferent lymphatics (21). HIV-1 was added to skin
cell emigrants or antigen-stimulated blood cells. Both cultures
became infected, as monitored by the release of p24 antigen
and reverse transcriptase into the culture medium (13, 22), but
it was not necessary to add a stimulus to the skin cultures (13).
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HIV-1-infected syncytia from both blood and skin expressed
p24 antigen (Fig. 1 A and C). However, the nuclei of the skin
syncytia lacked the Ki-67 antigen that is expressed in the nuclei
of cycling cells (23), whereas the nuclei of the blood cell
syncytia were all Ki-67-positive (compare Fig. 1 B with D). In
two experiments, 100% of the nuclei (85 counted) in skin
syncytia lacked Ki-67, whereas 94% of the nuclei (57 counted)
in blood-cell syncytia expressed Ki-67. Therefore, standard
T-cell activating stimuli, which are required for HIV-1 replication in isolated blood cells (1, 2, 4, 22), are unlikely to be
needed for replication in these mixtures of DCs and memory
T cells.
Expression of NF-KB and Spl Proteins in Leukocytes.
Given the essential role for NF-KB (Rel family) and Spl sites
inithe regulation of the HIV-1 promoter, we set out to study
the expression of Rel and Spl factors in different subsets of
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FIG. 1. HIV-1-infected syncytia contain cycling cells from blood
and noncycling cells from skin. Mixtures of allogeneic blood DCs and
T cells (mixed leukocyte reactions) or syngeneic DCs and T cells from
skin were infected with HIV-1IIIB. Cytocentrifuged cells were prepared after 5 days of infection and immunoperoxidase-stained for p24
and Ki-67. Skin syncytia were stained for HIV p24 antigen (A) or Ki-67
cell cycle antigen (B). Blood mixed leukocyte reaction syncytia were
stained for HIV p24 (C) or Ki-67 (D). Arrows indicate nuclei.

FIG. 2. Expression of NF-KB/Rel proteins and Spl in T cells and
DCs. (A) Immunofluorescence. Cytocentrifuged DCs (Left) and T cells
(Right) were immunolabeled with antibodies to Rel proteins or Spl. (B)
Immunoblot analysis. Total cell lysates (10 j.g) from subsets of mouse
leukocytes, peritoneal macrophages (M+), spleen (T cells and B cells),
and bone marrow DCs (BMDC) were probed with antibodies to the
indicated Rel family and Spl proteins. Bound antibodies were visualized
with peroxidase anti-immunoglobulin, followed by ECL.
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human and mouse leukocytes, especially DCs and T cells by
immunolabeling.
All Rel family proteins were readily identified in the cytoplasm
and nuclei of HLA-DR-positive DCs from human blood, but Spl
was not detectable (Fig. 2A Left). Previously onlyDrosophila cells
were known to lack Spl (24). Contrasting findings were made in
T cells from human blood. Cells stained weakly and primarily in
the cytoplasm with antibodies to the Rel family members, but Spl
was abundant in all T-cell nuclei (Fig. 2A Right).
Both cytofluorography and immunocytochemistry for Rel and
Spl gave the same results on mouse spleen DCs and T cells, as
presented above for human blood, i.e., high levels of Rel proteins
and low levels of Spl in DCs and vice versa in T cells. We used
immunoblot analysis to detect these proteins in different cell
subsets from mice (Fig. 2B) and human blood (data not shown).
Purified DCs that were generated from proliferating bone mar-
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row progenitors (17) contained all Rel proteins but lacked Spl.
T and B cells from spleen and macrophages elicited into the
peritoneal cavity had abundant Spl (Fig. 2B).
Analysis of NF-cB/Rel and Spl Binding Activities in Blood
Cells. The activity of these transcriptional control proteins was
then assessed with a consensus NF-KB oligonucleotide and
EMSA applied to several subsets of leukocytes. Data are
shown for human blood leukocytes, but comparable findings
were made with mouse cells (data not shown). The NF-KB
activity was primarily localized to the nucleus vs. cytoplasm in
every cell type. In each case, the activity was ablated by a
wild-type competing oligonucleotide but not by a mutated
sequence (Fig. 3A). NF-KB activity was greatly enhanced by
stimulation of T cells (phytohemagglutinin and phorbol 12myristate 13-acetate) and monocytes (lipopolysaccharide), but
B cells and DCs had readily detectable NF-KB activity in the
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FIG. 3. Activity of Rel proteins iind Sp I in human
leukocyte subsets. (A) EMSA with NF-KB consensus sequences and proteins fr-om the cytoplasm (cyt) and nuclear
extracts (NE) of T cells,
monocytes, B cells. and DCs that
had been enriched from human blood. The T cells were
studied without (unst) or with (stim) stimulation with
phytohemagglutinin (I gg/rnl) and phorbol 12-myristate
13-acetate (5 ng/ml) for 12 h. Monocytes wcrc studied
without or with stimulation with lipopolysaccharidc (100
pg/ml). To establish specificity, each gel shift was carried
out in the absence or prcsencc of a S0x molar excess of
competing wild-type (kB) or mutanit (mkB) oligonuLcleotides. (B) Supershift EMSA assays to identify the active Rel
family members in DCs and stimulated T cell nuclear
extracts. Each EMSA was carried out in the absence of
antiserum (-), with preimmune serum (P.I.), or with antibodics to RelB. c-Rel, p5V, or p65. Supcrshifted bands arc
shown with an a sterisk. Results with two experiments with
DC nuclear extracts are shown. (C) EMSA with Spl consensus scquences and proteins from the cytoplasm and
extracts of T cells (+- stimulation witlh phytohenmniuclear
agglutinin/phorbol 12-myristate 13-acetatc), B cells. DCs,
and macrophages (m4) that were unstimulated or stimulated with lipopolysaccharide (LPS). EMSA wats carried out
in the atbscnce or prcsence of competing wild-type (SPI) or
mutant (mSPI) oligonucleotidc.
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FIG. 4. Expression of Rel and Spl proteins in mixtures of DCs and T cells from skin. Explants of skin were cultured for 4 days and emigrate
cells were cytocentrifuged and stained with immunoperoxidase for c-Rel, ReOB, p65, Spl, and major histocompatibility complex class II. The large
DCs are readily distinguished from the small T cells, some of which are indicated with arrows.

absence of experimental stimulation (Fig. 3A). The NF-KB
binding activity detected in DCs was not inhibited when
extracts of unstimulated T cells were added (data not shown).
This indicates that the DC NF-KB binding activity is dominant
over that of the T cell.
Supershift assays were carried out to identify the active NF-KB
factors in human blood DCs and stimulated T cells (Fig. 3B). In
standard NF-KB EMSA assays, the p65 and p50 components of
the heterodimer migrate as separate species. Antibodies to p50,
p65, and Rel-B produced a supershift of the corresponding
NF-KB species from DCs, whereas strong supershifts in stimulated T cells were observed with anti-p50 and anti-p65.
For Spl EMSA assays, activity was noted in unstimulated T
cells and stimulated macrophages but was weak in B cells and
not detectable in DCs (Fig. 3C). The lack of detectable binding
of DC nuclear extracts to the Spl consensus sequence suggested that Sp2 and Sp3 (25) were also absent in these extracts.
Detection of NF-cB/Rel and Spl Proteins in Skin Cells.
Next, we evaluated the expression of NF-KB/Rel and Spl in
populations of cells isolated from skin. These contain DCs and
T cells that form tight conjugates and are permissive to HIV-1
(13). For both mouse and human skin, the DCs are large and

irregularly shaped, while the T cells are small and round. The
DCs are known to be major histocompatibility complex class
1I-bright and CD3-negative, while the T cells are class II
negative and CD3-positive. In cells from mouse and human
skin, the large DCs showed strong nuclear and cytoplasmic
labeling with antibodies to all the Rel family members (c-Rel,
RelB, and p65, shown here, but also p50 and p52, not shown),
but no labeling with anti-Spl (Fig. 4). In contrast, the T cells
showed weak labeling with all anti-Rel antibodies except p65,
but strong nuclear labeling with anti-Spl.
Syncytia of HIV-1-Infected Skin Cells Coexpress NFcB/Rel and Spl Transcription Factors. The studies were then
repeated on HIV-1-infected human skin cells. These cultures
contained numerous syncytia. Prior work had shown that the
syncytia are heterologous (double labeling with the CDla
marker for DCs and the CD3 marker for T cells) and are the
major site of viral replication (13). Fig. 5 shows three typical
syncytia that were double labeled for the Rel proteins (visualized by fluorescein isothiocyanate-conjugated antibody) and
Spl (visualized by Texas red-conjugated antibody). These
syncytia show RelB, p50, and p65 cytoplasmic and nuclear
staining, p50 being the strongest. Spl is in a fraction of the

.6:
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FIG. 5. Coexpression of NF-

KB/Rel and Spl proteins in heterologous syncytia of skin DCs and T
cells. Shown here is double immunofluorescent labeling of syncytia for
RelB (green) and Spl (red) on the
left or p65 (green) and Spi (red) on
the right or superimposed staining
of p50 and Spl on the right in the
lower box. Some T-cell nuclei are
indicated by arrows.
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FIG. 6.

Cooperation

of DC extracts and

Spl for activation of the HIV-1 promoter.
Nuclear extracts (25-75 ,ug) from the indicated cells were tested for the ability to transactivate the HIV-1 promoter in a cell-free
system. DC extracts were assayed alone or in
combination with Spl (1 footprinting unit).
The transcribed RNA was purified, resolved
in a urea/PAGE gel, and autoradiographed.
An arrow indicates the expected size of transcripts.

nuclei in these syncytia, presumably those derived from the T
cells. The efficiency with which virus replicates in skin syncytia
may be due to the colocalization of these requisite transcription control proteins for HIV-1 in the syncytia.
DC Nuclear Extracts Transactivate the HIV-1 Promoter.
We have looked at the ability of DC and T-cell nuclear extracts
to activate the HIV-1 promoter. Nuclear extracts from HeLa
and stimulated T cells show transcriptional activity (Fig. 6).
However, DC nuclear extracts needed to be supplemented
with Spl to drive transcription in vitro.

Downloaded at Rockefeller University Library on July 29, 2020

DISCUSSION

Prior studies in cell lines have identified an important role for
NF-KB and Spl proteins in the transcriptional control of the
HIV-1 (6, 26, 27). In primary cells, both monocytes and T cells
will support replication of HIV-1, but the cells must be
stimulated, presumably to activate NF-KB and thereby initiate
HIV-1 transcription. DCs contain high levels of all known Rel
family members and express strong activity for NF-KB in DNA
binding. This may reflect stimulation with, for example, granulocyte-macrophage colony-stimulating factor during DC development. However, DCs lack Spl, whereas T cells and
monocytes express Spl in an active form. These findings were
made with DCs from human blood and skin, as well as mouse
spleen, bone marrow, and skin. The absence of Spl could
account for the fact that isolated DCs do not support a
productive infection with HIV-1 (13, 22, 28). T cells from
several sites, which also do not support productive HIV-1
infection unless stimulated, lack active Rel proteins but have
abundant Spl.
When HIV-1 infects mixtures of DCs and T cells (and
possibly, when DCs conjugate to "latently" infected T cells and
vice versa), expression of low levels of envelope proteins might
mediate cell fusion via the CD4 molecule that can be expressed
by either cell type. As a result of the formation of these unusual
heterologous syncytia, high levels of active Rel and Spl
proteins are brought together into the same cell. The HIV-1
promoter should then be stimulated strongly, leading to the
marked production of virions even in the absence of standard
stimuli.
DCs are present in the linings of all of the organs involved
in the sexual transmission of HIV-1, while DC-T-cell conjugates are found in the afferent lymphatics of all four mammalian species that have been studied including humans (for
review, see refs. 29-33). The capacity of HIV-1 to create
heterologous syncytia between these two CD4+ cell types can
bring together requisite transcriptional control proteins for the
viral promoter. To our knowledge, this phenomenon of heterologous syncytia and mixing of transcriptional control proteins has not been seen previously in viral infection (or other
circumstances) and may contribute to chronic HIV-1 replication in situ.
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